Dr Kultar Singh Garcha, an NHS GP and chief medical officer at Flow Neuroscience, criticised the report
A high risk group for suicide and untreated mental illness are under-represented in the government’s Men’s Health…
Continue Reading
Delirium affects 50% of hospitalized older adults and 80% of ICU patients, yet detection rates are as low as 20–30% with traditional methods. Natural language processing (NLP) offers potential for automated detection from clinical…
Continue Reading
Patients with clear cell renal cell carcinoma (ccRCC) face a high risk of recurrence after surgery, but existing clinical tools based on clinicopathological factors or costly molecular profiling often lack precision and clinical feasibility….
Continue Reading
Background: Major depressive disorder is often a recurrent condition, with a high risk of relapse for individuals remitted from depression. Early detection of relapse is critical to improve clinical outcomes. Mobile health (mHealth) technologies…
Continue Reading
Dr. Richard S. Isaacson, Neurologist at The Institute for Neurodegenerative Diseases (IND)
Dr. Kellyann Niotis M.D. Neurologist at The Institute for Neurodegenerative Diseases (IND)
Hundreds of millions of people worldwide live with a high risk of…
Continue Reading
Three diabetes apps have been made available across Wales to complement a government face-to-face programme that has helped more than 10,000 people.
NHS Wales has invested in a Wales-wide license for the apps that…
Gretchen Zimmermann, MBA, RD, VP of Clinical Strategy at Vida Health
The false belief that people with obesity do not have eating disorders is one of the most harmful misconceptions in obesity care. In reality,…
Continue Reading
Findings from a previous study (ClinicalTrials.gov: NCT05118035) demonstrated that an AI-enabled electrocardiogram (AI-ECG), combining AI reports and physician alerts, effectively identified hospitalized patients at high risk of mortality and reduced all-cause mortality. This study…
Continue Reading
This video shares an in production use case of an automation with well designed workflow, that overcomes many of the challenges faced by back-office operations in health care. The automation was carried out by…
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
